(Q35574863)

8 August 2017

1 reference

title

A systematic overview of radiation therapy effects in non-small cell lung cancer (English)

1 reference

8 August 2017

A Systematic Overview of Radiation Therapy Effects in Non-Small Cell Lung Cancer (English)

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

28 March 2024

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

28 March 2024

4

Eva Cavallin-Ståhl

1 reference

8 August 2017

Florin Sirzén

1

1 reference

8 August 2017

Elisabeth Kjellén

2

1 reference

8 August 2017

Sverre Sörenson

3

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14596509

28 March 2024

publication date

1 January 2003

1 reference

8 August 2017

1 reference

8 August 2017

42

1 reference

8 August 2017

5-6

1 reference

8 August 2017

493-515

1 reference

Passive smoking and lung cancer: a cumulative meta-analysis

8 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

An update on management of lung cancer--Acta Oncologica Lecture-Västerås 21 March 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Revisions in the International System for Staging Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Fractionation and dose in thoracic radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Biological factors influencing optimum fractionation in radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Point: the potential importance of elective nodal irradiation in the treatment of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Three-dimensional radiation treatment planning study for patients with carcinoma of the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Staging non-small cell lung cancer with whole-body PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Interaction between novel anticancer agents and radiation in non-small cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Is preoperative or postoperative radiation therapy indicated in non-small cell cancer of the lung?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Palliative radiotherapy for lung cancer: two versus five fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Contemporary brachytherapy approaches in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

The epidemiology of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Survival analysis of untreated patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

21 January 2018

Experience with CHART

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

It's about time, or is it volume, fractionation, or technique?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Inoperable non-small cell lung cancer: radiation with or without chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

A prospective randomized comparison of radiation therapy plus lonidamine versus radiation therapy plus placebo as initial treatment of clinically localized but nonresectable nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310014453

Cancer chemotherapy and biological response modifiers

21 January 2018

3

12

443

Hansen HH

1991

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

28 March 2024

10

311

M1

Non-small Cell Lung Cancer Collaborative Group

publication date

1995

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology

28 March 2024

11

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

28 March 2024

26

19

P1

Hayman JA

2001

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

British Journal of Cancer

28 March 2024

46

78

P1

Saunders MI

1998

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

28 March 2024

47

16

P1

Mehta MP

1998

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

28 March 2024

Cancer Treatment Reports

65

62

327

Bitran JD

1978

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

28 March 2024

Cancer Treatment Reports

66

71

895

Eagan RT

1987

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life

28 March 2024

71

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

Journal of the National Cancer Institute

28 March 2024

74

85

C3

Gregor A

1993

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

28 March 2024

76

4

C2

Crino L

1993

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

28 March 2024

77

12

C3

Kubota K

1994

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol

28 March 2024

82

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer

28 March 2024

83

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study

28 March 2024

84

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer

28 March 2024

89

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group

28 March 2024

90

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

28 March 2024

93

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

28 March 2024

100

13

P1

Albain KS

1995

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

28 March 2024

101

16

P1

Eberhardt W

1998

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

28 March 2024

102

15

P1

Choi NC

1997

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

28 March 2024

103

17

P1

Thomas M

1999

1 reference

https://api.crossref.org/works/10.1080/02841860310014453

28 March 2024

Identifiers

1 reference

8 August 2017

1 reference